Set your preference
Font Scaling
Default
Page Scaling
Default
Color Adjustment
IITK

Switchable Tandem CAR-T Cells Targeting tMUC1 and ROR1 for Breast Cancer Immunotherapy

Switchable Tandem CAR-T Cells Targeting tMUC1 and ROR1 for Breast Cancer Immunotherapy

Switchable Tandem CAR-T Cells Targeting tMUC1 and ROR1 for Breast Cancer Immunotherapy (Prof. Sivaprakash, Biological sciences and Bioengineering)

The project aims to develop a proof of concept on the generation of bi-specific CAR-T cells combined with knockout of PD-1 immune checkpoint protein to overcome immune suppression of T cells in the tumor microenvironment and promote TNBC tumor killing. In addition, we will incorporate the safety switch (suicide gene) RQR8 into our CAR molecule, which will allow for the selective removal of administered CAR-T cells in the event of toxicity.

More Research Highlights